Chemoinformaics analysis of 1,7-DIPHENYLHEPT-4-EN-3-ONE
| Molecular Weight | 264.368 | nRot | 7 |
| Heavy Atom Molecular Weight | 244.208 | nRig | 14 |
| Exact Molecular Weight | 264.151 | nRing | 2 |
| Solubility: LogS | -4.997 | nHRing | 0 |
| Solubility: LogP | 4.32 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 12 |
| nHA | 1 | APOL | 45.8679 |
| nHD | 0 | BPOL | 20.9321 |
| QED | 0.678 |
| Synth | 1.855 |
| Natural Product Likeliness | 0.966 |
| NR-PPAR-gamma | 0.286 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.969 |
| Pgp-sub | 0.039 |
| HIA | 0.004 |
| CACO-2 | -4.737 |
| MDCK | 0.0000169 |
| BBB | 0.287 |
| PPB | 0.980897 |
| VDSS | 0.713 |
| FU | 0.00479792 |
| CYP1A2-inh | 0.961 |
| CYP1A2-sub | 0.48 |
| CYP2c19-inh | 0.957 |
| CYP2c19-sub | 0.091 |
| CYP2c9-inh | 0.905 |
| CYP2c9-sub | 0.28 |
| CYP2d6-inh | 0.34 |
| CYP2d6-sub | 0.441 |
| CYP3a4-inh | 0.372 |
| CYP3a4-sub | 0.495 |
| CL | 8.096 |
| T12 | 0.753 |
| hERG | 0.318 |
| Ames | 0.073 |
| ROA | 0.03 |
| SkinSen | 0.968 |
| Carcinogencity | 0.366 |
| EI | 0.981 |
| Respiratory | 0.921 |
| NR-Aromatase | 0.025 |
| Antiviral | No |
| Prediction | 0.689464 |